SIGN 133: Management of hepatitis C

Zusammenfassung

SIGN 133 • Management of hepatitis C A national clinical guideline July 2013 Evidence Help us to improve SIGN guidelines - click here to complete our survey KEY TO EVIDENCE STATEMENTS AND GRADES OF RECOMMENDATIONS LEVELS OF EVIDENCE 1 ++ High quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low risk of bias 1 + Well conducted meta-analyses, systematic reviews, or RCTs with a low risk of bias 1 - Meta-analyses, systematic revie

Kerninformationen

More information on accreditation can be viewed at www.evidence.nhs.uk Healthcare Improvement Scotland (HIS) is committed to equality and diversity and assesses all its publications for likely impact on the six equality groups defined by age, disability, gender, race, religion/belief and sexual or...

Scottish Intercollegiate Guidelines Network Management of hepatitis C A national clinical guideline July 2013 Scottish Intercollegiate Guidelines Network Gyle Square, 1 South Gyle Crescent Edinburgh EH12 9EBA www.sign.ac.uk First published July 2013 ISBN 978 1 909103 13 9 Citation text Scottish ...

The prevalence of infection varies between population groups, ranging from 50% in injecting drug users (IDU) to less than 0.04% among new blood donors. 1 Up to 80% of patients infected with HCV become chronically infected and most of these patients will show evidence of chronic hepatitis. 2 Hepati...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen